Logistics & Transportation

Articles

How drugmakers can navigate the program’s pricing challenges and regulatory developments.

Expansion allows facility to provide E2E services in one location, including commercial manufacturing.

The company will occupy approximately 62,000 square feet of the new building.  

The plant— dedicated to cell and gene therapy development—welcomes additional warehouse space, and aims to meet commercial needs.

How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.

Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.

Rob Besse is a Vice President and Subject Matter Expert in
Distribution at Archbow Consulting.

The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.

CDMO’s Taoyuan City plant is set to provide customers with products ranging from emulsions to gels. 

CDMO’s Turku addition will span over 69,000 square feet and support the production of ATMPs.

Sterile injectable plant—struck by tornado—is currently being assessed.